WCLC 2025 - Posters & ePosters-EP.03.12 Sex-Specific Blood-Based Immune Signatures Predict Response to First-Line Immunotherapy in Advanced NSCLC: A Prospective Translational Study

EP.03.12 Sex-Specific Blood-Based Immune Signatures Predict Response to First-Line Immunotherapy in Advanced NSCLC: A Prospective Translational Study

Asset Subtitle

Amanda Tufman

Meta Tag

Speaker Amanda Tufman

Topic Tumor Biology – Translational Biology